Table 5 Malaria national intervention policy and factor loadings
Malaria national intervention policy and strategy adoption | Factor 1 | Factor 2 | Factor 3 | Factor 4 | Factor 5 | Factor 6 |
|---|---|---|---|---|---|---|
ITNs/LLINs are distributed free of charge | − 0.31 | − 0.22 | − 0.59 | 0.56 | 0.32 | 0.06 |
ITNs/LLINs are distributed to all age groups | 0.03 | 0.58 | − 0.11 | 0.66 | 0.01 | − 0.40 |
ITNs/LLINs distributed through mass campaigns to all age groups | − 0.47 | 0.41 | − 0.5 | 0.18 | 0.29 | − 0.31 |
IRS is recommended by malaria control programme | − 0.16 | 0.68 | 0.11 | − 0.47 | 0.19 | − 0.34 |
DDT is used for IRS | − 0.03 | 0.57 | 0.47 | − 0.04 | 0.61 | 0.25 |
IPTp is used to prevent malaria during pregnancy | − 0.66 | 0.05 | 0.6 | 0.38 | − 0.15 | 0.06 |
Seasonal malaria chemoprevention (SMC or IPTc) | − 0.67 | − 0.08 | 0.65 | 0.26 | − 0.02 | − 0.02 |
Patients of all ages should get diagnostic test | 0.55 | 0.01 | 0.66 | 0.5 | − 0.05 | 0.03 |
Malaria diagnosis is free of charge in the public sector | 0.67 | 0.21 | 0.05 | 0.33 | 0.43 | 0.34 |
RDTs are used at community level | − 0.41 | 0.35 | − 0.43 | − 0.11 | − 0.07 | 0.61 |
G6PD test is recommended before treatment with primaquine | 0.40 | 0.25 | − 0.31 | 0.49 | − 0.54 | 0.11 |
ACT for treatment of Plasmodium falciparum | − 0.40 | 0.82 | 0.08 | − 0.08 | − 0.37 | 0.02 |
Pre-referral treatment with quinine or artemether IM or artesunate supp | − 0.70 | 0.32 | − 0.19 | 0.15 | − 0.12 | 0.21 |
Single dose of primaquine is used as gametocidal medicine for Plasmodium falciparum | 0.68 | 0.53 | − 0.01 | − 0.05 | 0.02 | 0.1 |
Primaquine is used for radical treatment of Plasmodium vivax | 0.91 | 0.01 | − 0.17 | 0.11 | 0.05 | − 0.13 |
Directly observed treatment with primaquine is undertaken | 0.66 | 0.43 | 0.10 | − 0.22 | − 0.29 | 0.04 |